Abstract
Idiopathic portal hypertension (IPH) is a disease presenting as non-cirrhotic portal hypertension due to a presinusoidal portal blood flow block and increased portal blood flow with an enlarged spleen, although the etiologic factors have not been identified. IPH is most common in middle-aged females and is predominant in females versus males in the overall population in Japan. The major signs and symptoms are pancytopenia with splenomegaly and gastroesophageal varices. The clinical manifestations are relatively mild and insidious in most of the patients, except in the case of variceal hemorrhage. A high incidence of portal vein thrombosis is also characteristic. Diagnosis is made by the differentiating IPH from the diseases of portal hypertension with identified causes because there are no specific clinical findings for the diagnosis of IPH. Portal and hepatic venography or liver histology is helpful for the diagnosis. The treatment of portal hypertension-related problems is the same as for problems related to liver cirrhosis. The clinical course and overall survival are well maintained in patients for whom gastroesophageal varices are effectively controlled. However, complications such as refractory ascites or intestinal ectopic varices may appear in the late stages of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Okuda K. Noncirrhotic portal hypertension. In: Okuda K, Mitchell DG, Itai Y, Ariyama J, editors. Hepatobiliary diseases pathophysiology and imaging. London: Blackwell Science; 2001. p. 287–314.
Banti G. Del l’anemia splenica. Arch di Scuola d’Anat Patol (Firenze). 1983;2:53–122.
Banti G. Ueber Morbus Banti Folia Haematol. 1910;10:33–74.
Hsia DYY, Gellis SS. Portal hypertension in infants and children. Am J Dig Child. 1955;90:290–8.
Polish E, Christie J, Cohen A, et al. Idiopathic portal hypertension (Banti’s syndrome). Ann Intern Med. 1962;56:624–7.
Williams P, Parsonson A, Somers K. Portal hypertension in idiopathic tropical splenomegaly. Lancet I. 1966;287:329–33.
Ramalingaswarmi B, Wig HL, Sarma SK. Cirrhosis of the liver in northern India: pathological study. Arch Intern Med. 1962;110:350–8.
Mikkelsen WP, Edmondson HA, Peters RL, et al. Extra- and intra-hepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg. 1965;162:602–20.
Boyer JL, Sengupta KP, Biswas SK, et al. Idiopathic portal hypertension: comparison with portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967;66:41–68.
Schouten JNL, Garcia-Pagan JC, Valla DC, Janssen HLA. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071–81.
Kotani K, Kawabe J, Morikawa H, et al. Comprehensive screening of gene function and networks by DNA microarray analysis in Japanese patients with idiopathic portal hypertension. Mediat Inflamm. 2015;2015:349215. https://doi.org/10.1155/2015/349215. Epub 2015 Oct 4.
Tsuneyama K, Harada K, Katayanagi K, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a reviewer of literature. J Gastroenterol Hepatol. 2002;17:217–23.
Okabayashi A. Experimental production of noncirrhotic portal hypertension and splenomegaly with prolonged antigenic stimulation. In: Okuda K, Omata M, editors. Idiopathic portal hypertension. Tokyo: University of Tokyo press; 1983. p. 197–217.
Kono K, Ohnishi K, Omata M, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic E. coli in rabbits. Gastroenterology. 1988;94:787–96.
Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rat may be mediated by growth factor beta-1. J Gastroenterol Hepatol. 2002;17:59–65.
Sato Y, Nakanuma Y. Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Histol Histopathol. 2013;28:145–54.
Morikawa H, Tamori A, Nishiguchi S, et al. Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Mol Med. 2007;13:240–5.
Hirota Y, Annual Report of Research Committee on Portal Hemodynamics Abnormalities, The Ministry of Health Labor and Welfare of Japan;2006:82–92 (Japanese).
Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis. 2002;22:59–71.
Futagawa S, Fukazawa M, Horisawa M, et al. Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR. 1980;134:917–23.
Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984;86:600–10.
Futagawa S, Fukazawa M, Musha H, et al. Hepatic venography in noncirrhotic idiopathic portal hypertension. Radiology. 1981;141:303–8.
Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut. 2002;51:275–80.
Matsutani S, Maruyama H, Akiike T, et al. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int. 2005;25:978–83.
Matsutani S. Blood coagulation inhibitors and portal vein thrombosis in patients with portal hypertension. Annual Report of Research Committee on Portal Hemodynamics Abnormalities, The Ministry of Health Labor and Welfare of Japan;2009:31–5 (Japanese).
Ohnishi K, Saito M, Sato S, et al. Portal hemodynamics in idiopathic portal hypertension (Banti’s syndrome) comparison with chronic persistent hepatitis and normal subjects. Gastroenterology. 1987;92:751–8.
Furuichi Y, Moriyasu F, Taira J, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol. 2013;48:1061–8.
Qureshi K, Patel S, Meillier A. The use of thrombopoietin receptor agonist for correction of thrombocytopenia prior to elective procedures in chronic liver diseases: review of current evidence. Int J Hepatol. 2016;2016:1802932. Epub 2016 Oct 9.
Ichimura S, Sasaki R, Takemura Y, et al. The prognosis of idiopathic portal hypertension in Japan. Intern Med. 1993;32:441–4.
Murai Y, Ohfuji S, Fukushima W, et al. Prognostic factors in patients with idiopathic portal hypertension: two Japanese nationwide epidemiological surveys in 1999 and 2005. Hepatol Res. 2012;42:1211–20.
Sawada S, Sato Y, Aoyama H, et al. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of annuals of pathological autopsy cases in Japan. J Gastroenterol Hepatol. 2006;22:204–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Matsutani, S. (2019). Idiopathic Portal Hypertension. In: Obara, K. (eds) Clinical Investigation of Portal Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-10-7425-7_57
Download citation
DOI: https://doi.org/10.1007/978-981-10-7425-7_57
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7424-0
Online ISBN: 978-981-10-7425-7
eBook Packages: MedicineMedicine (R0)